These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4402031)

  • 1. Preliminary evidence that syrosingopine produces a selective depletion of central stores of sympathomimetic amines.
    Turner TA; Spencer PS
    J Pharm Pharmacol; 1971 Dec; 23(12):977-8. PubMed ID: 4402031
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of (+-)-p-chloroamphetamine on the susceptiblity to seizures and on the monoamine level in brain and heart of mice and rats.
    Pfeifer AK; Galambos E
    J Pharm Pharmacol; 1967 Jun; 19(6):400-2. PubMed ID: 4382372
    [No Abstract]   [Full Text] [Related]  

  • 3. Reserpine-induced depletion of the norepinephrine stores: is it a reliable criterion for the classification of the mechanism of action of sympathomimetic amines?
    Luchelli-Fortis MA; Langer SZ
    J Pharmacol Exp Ther; 1974 Mar; 188(3):640-53. PubMed ID: 4816331
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of drugs on monoamines and their metabolites in the brain of birds and mammals.
    Juorio AV
    J Physiol; 1966 Oct; 186(2):70P-72P. PubMed ID: 5972133
    [No Abstract]   [Full Text] [Related]  

  • 5. The depletion and recovery of noradrenaline in the brain and some sympathetically innervated mammalian tissues after tetrabenazine.
    Häggendal J
    J Pharm Pharmacol; 1968 May; 20(5):364-7. PubMed ID: 4385439
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S
    Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of an amnesic dose of reserpine, syrosingopine or guanethidine on the levels of whole brain dopamine and norepinephrine in the mouse.
    Brown OM; Palfai T; Wichlinski L
    Pharmacol Biochem Behav; 1981 Dec; 15(6):911-4. PubMed ID: 6119704
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective depleting effect of syrosingopine on brain catecholamine levels with relation to morphine analgesia in the rat.
    Furukawa T; Sano T; Kohno Y; Koga M; Nagasaki N
    Pharmacol Biochem Behav; 1976 Apr; 4(4):419-25. PubMed ID: 6976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metatyrosine as a tool for selective protection of catecholamine stores against reserpine.
    Carlsson A; Lindqvist M
    Eur J Pharmacol; 1967 Dec; 2(3):187-92. PubMed ID: 5590341
    [No Abstract]   [Full Text] [Related]  

  • 10. The interference of tetrabenazine, benzquinamide and prenylamine with the action of reserpine.
    Carlsson A; Lindqvist M
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):112-20. PubMed ID: 6013085
    [No Abstract]   [Full Text] [Related]  

  • 11. Indirect biochemical evidence that reserpine methiodide produces selective depletion of peripheral biogenic amines in rats.
    Sreemantula S; Boini KM; Koppula S; Kilari EK; Nammi S
    Pharmazie; 2005 Apr; 60(4):294-7. PubMed ID: 15881611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective potentiation of sympathomimetic amines by reserpine. syrosingopine and 2,6-xylylcholine ether bromide (TM-10) in the dog.
    ROSS CA; WENGER HC; LUDDEN CT; STONE CA
    Arch Int Pharmacodyn Ther; 1963 Mar; 142():141-51. PubMed ID: 13975072
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the question of a "reserpine-like" effect of prenylamine (Segontin)].
    Grobecker H; Palm D; Bak IJ; Schmid B
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):215-6. PubMed ID: 5804244
    [No Abstract]   [Full Text] [Related]  

  • 14. Depression and recovery of the electrocorticogram, behavior, and brain amines in rats treated with reserpine.
    Pirch JH; Rech RH; Moore KE
    Int J Neuropharmacol; 1967 Sep; 6(5):375-85. PubMed ID: 6055317
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of 4-(3-indolyl-alkyl)piperidine derivatives on uptake and release of noradrenaline, dopamine and 5-hydroxytryptamine in rat brain synaptosomes, rat heart and human blood platelets.
    Le Fur G; Uzan A
    Biochem Pharmacol; 1977 Mar; 26(6):497-503. PubMed ID: 849346
    [No Abstract]   [Full Text] [Related]  

  • 16. Modification of action of sympathomimetic amines by triiodothyronine.
    Bhagat B; Saini N; West WL; Booker WM
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):126-37. PubMed ID: 5834931
    [No Abstract]   [Full Text] [Related]  

  • 17. Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase.
    Corrodi H; Fuxe K; Hökfelt T
    Life Sci; 1966 Apr; 5(7):605-11. PubMed ID: 5960198
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of gamma-aminobutyric acid on brain serotonin and catecholamines.
    Yessaian NH; Armenian AR; Buniatian HC
    J Neurochem; 1969 Oct; 16(10):1425-33. PubMed ID: 5309558
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.
    Lidbrink P; Jonsson G; Fuxe K
    Brain Res; 1974 Mar; 67(3):439-56. PubMed ID: 4470434
    [No Abstract]   [Full Text] [Related]  

  • 20. Steric aspects of adrenergic drugs. XIV. Actions and interactions of "indirectly" acting L(+)-isomers and desoxy derivatives of sympathomimetic amines.
    Patil PN; Patel DG; Tye A
    Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):32-43. PubMed ID: 5391836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.